Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease
Abstract To assess the efficacy and safety of eltrombopag in connective tissue disease (CTD)-immune thrombocytopenia (ITP), we conducted this single-center retrospective observational study, including patients with refractory CTD-ITP who were treated with eltrombopag between January 2018 and August...
Saved in:
Main Authors: | , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/efe7af08d0f3455089981a6d8628972c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|